BrightAccountsProduction v1.0.0 v1.0.0 2024-07-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts Wholesale of pharmaceutical goods 25 August 2026 5 5 NI680326 2025-06-30 NI680326 2024-06-30 NI680326 2023-06-30 NI680326 2024-07-01 2025-06-30 NI680326 2023-07-01 2024-06-30 NI680326 uk-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 NI680326 uk-curr:PoundSterling 2024-07-01 2025-06-30 NI680326 uk-bus:AbridgedAccounts 2024-07-01 2025-06-30 NI680326 uk-core:CapitalReserve 2025-06-30 NI680326 uk-core:CapitalReserve 2024-06-30 NI680326 uk-countries:Spain 2024-07-01 2025-06-30 NI680326 uk-bus:Director1 2024-07-01 2025-06-30 NI680326 uk-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 NI680326 uk-bus:Micro-entities 2024-07-01 2025-06-30 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI680326
 
 
Farmadosis Ltd
 
Unaudited Financial Statements
 
for the financial year ended 30 June 2025
Farmadosis Ltd
Company Registration Number: NI680326
STATEMENT OF FINANCIAL POSITION
as at 30 June 2025

    2025   2024
  £   £
ASSETS
Fixed Assets 99,327   9,914
Current assets 265,253   188,131
Prepayments and accrued income 950   683
  ─────────   ─────────
  365,530   198,728
  ═════════   ═════════
CAPITAL, RESERVES AND LIABILITIES
Capital and Reserves 8,424   32,217
Creditors: amounts falling due within one year 337,456   137,973
Accruals and deferred income 19,650   28,538
  ─────────   ─────────
  365,530   198,728
  ═════════   ═════════
 
Notes to the Financial statements
   
1. General Information
 
Farmadosis Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI680326. The registered office of the company is 5 Mallusk Drive, Newtonabbey, Co Antrim, BT36 4GX, Northern Ireland which is also the principal place of business of the company. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
       
2. Employees
 
The average monthly number of employees, including director, during the financial year was:
 
  2025 2024
  Number Number
 
Employees 5 5
  ═════════ ═════════
   
3. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.
     
For the financial year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
 
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account.
 
Approved by the Director on 25 August 2026 and signed by:
 
   
________________________________  
Ross Gardiner  
Director